Clinical Research Directory
Browse clinical research sites, groups, and studies.
13-cis Retinoic Acid (Isotretinoin) and Sperm Production
Sponsor: University Hospital, Strasbourg, France
Summary
This study aims to evaluate the effectiveness of weekly administration of isotretinoin (40 mg) in increasing sperm production in men with oligozoospermia, a condition characterized by a low sperm count. Participants will be randomized into two groups: one receiving isotretinoin and the other a placebo. The primary outcome will be the change in sperm production over 20 weeks of treatment.
Key Details
Gender
MALE
Age Range
21 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-03-01
Completion Date
2027-12-01
Last Updated
2024-11-25
Healthy Volunteers
No
Conditions
Interventions
Isotretinoin
ARESPERM is a multicenter, randomized, double-blind, placebo-controlled study that assesses whether a weekly dose of isotretinoin can stimulate spermatogenesis in men with oligozoospermia. The study hypothesizes that isotretinoin can trigger the differentiation of spermatogonial cells, leading to improved sperm production.
Control group (placebo)
placebo administration
Locations (1)
CECOS Alsace Strasbourg
Schiltigheim, France